Skip to main navigation Skip to search Skip to main content

Ampicillin—gentamicin versus ampicillin alone for prolonged prelabor rupture of membranes at term in group B streptococcus—negative patients: a randomized controlled trial

  • Raneen Abu Shqara
  • , Daniel Glikman
  • , Gabriela Goldinfeld
  • , Dunia Hassan
  • , Amal Orabi
  • , Nadir Ganem
  • , Lior Lowenstein
  • , Maya Frank Wolf
  • Western Galilee Medical Center of Nahariya
  • Bar-Ilan University

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Background Prolonged prelabor rupture of membranes at term increases the risk of maternal and neonatal infections, yet the optimal prophylactic antibiotic regimen in patients with confirmed negative group B Streptococcus colonization remains unclear. Objective We compared maternal and neonatal outcomes between 2 prophylactic antibiotic regimens, ampicillin plus gentamicin vs ampicillin alone, in patients with term prelabor rupture of membranes and confirmed negative group B Streptococcus colonization. Study Design This single-center, randomized controlled trial was conducted at a tertiary university-affiliated hospital between November 2022 and July 2025. Eligible participants were women with singleton term pregnancies, prelabor rupture of membranes ≥18 hours, and negative group B Streptococcus colonization. Patients were randomized 1:1 to receive intravenous ampicillin (2 g every 6 hours) plus gentamicin (5 mg/kg every 24 hours) or ampicillin alone, initiated 18 hours after prelabor rupture of membranes. The co-primary outcomes were the incidences of clinical chorioamnionitis and endometritis. Secondary outcomes included intrapartum fever, postpartum maternal infections, postpartum stay ≥5 days, and neonatal morbidity. Chorioamniotic cultures were obtained postpartum. Analyses were performed on an intention-to-treat basis. Results A total of 207 women were randomized (103 to ampicillin–gentamicin; 104 to ampicillin alone).Clinical chorioamnionitis occurred less frequently in the ampicillin–gentamicin group than in the ampicillin-alone group (1.9% vs 10.6%; P=.019; number needed to treat, 11.5; 95% confidence interval, 7–45). The endometritis rates were similar between the groups. Postpartum infectious morbidity was also lower in the combined-treatment group (1.9% vs 9.6%; P =.033), as was the rate of postpartum hospitalization ≥5 days (3.9% vs 13.5%; P =.024). In the ampicillin–gentamicin group, admission to the neonatal intensive care unit due to suspected early-onset sepsis was lower (2.9% vs 8.7%, P =.031) and positive chorioamniotic cultures were less frequent (20.9% vs 36.7%; P =.029). The prevalence of Enterobacteriaceae spp. was lower (12.1% vs 25.6%; P =.033). Conclusion Among patients with confirmed negative group B Streptococcus colonization and with prolonged term prelabor rupture of membranes, clinical chorioamnionitis and postpartum maternal infectious morbidity were lower following prophylactic administration of ampicillin plus gentamicin compared to ampicillin monotherapy. Broader Gram-negative coverage may improve maternal outcomes and warrants further evaluation.

Original languageEnglish
Pages (from-to)1768-1776
Number of pages9
JournalAmerican Journal of Obstetrics and Gynecology
Volume234
Issue number6
DOIs
StatePublished - Jun 2026

Bibliographical note

Publisher Copyright:
© 2026 Elsevier Inc.

Keywords

  • E coli
  • Enterobacteriaceae
  • antibiotic prophylaxis
  • clinical chorioamnionitis
  • early-onset sepsis
  • intrapartum fever
  • maternal infection
  • neonatal sepsis

Fingerprint

Dive into the research topics of 'Ampicillin—gentamicin versus ampicillin alone for prolonged prelabor rupture of membranes at term in group B streptococcus—negative patients: a randomized controlled trial'. Together they form a unique fingerprint.

Cite this